Bellwether J&J Squashes First-Quarter Views; Will Other Medical Stocks Follow?

Johnson & Johnson topped first quarter expectations and hiked its quarterly dividend by a nickel, leading JNJ stock to inch higher Tuesday. Medical device and drug sales rose.
Read More